Abstract:Neonates are known to exhibit increased susceptibility to bacterial and viral infections and increasing evidence demonstrates that the increased susceptibility is related to their attenuated immune response to infections. The lung is equipped with an innate defense system involving both cellular and humoral mediators. The present study was performed to characterize the expression of inflammatory mediators in the lung of neonatal rats in comparison with older animals. Rats at postnatal day 1 (P1), P21, and P70 were treated with saline or 0.25 mg/kg lipopolysaccharide (LPS) via intraperitoneal injection. Two hours later, animals were sacrificed and the transcriptional response of key inflammatory mediators and enzyme activity of myeloperoxidase (MPO) in the lung of these animals were examined. LPS-induced messenger RNA (mRNA) expression of pro-inflammatory cytokines, namely interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, antiinflammatory cytokines, namely IL-10 and IL-1 receptor antagonist (IL-1ra), and chemokines, namely macrophage inflammatory protein (MIP)-1β, MIP-2, and monocyte chemotactic protein-1, in P1 lung was much reduced compared to that in P21 and P70 animals at 2 hours postinjection. These data suggest that LPS-induced transcriptional response of cytokines and chemokines was much reduced in P1 lung even though the protein levels of these genes were not ascertained and mRNA levels of these genes may not reflect their final protein levels. MPO activity in LPS-treated P1 lung was also significantly attenuated compared to that in LPS-treated P70 lung, suggesting impaired neutrophil infiltration in P1 lung at 2 hours following LPS treatment. In parallel, the baseline mRNA expression of LPS-binding protein (LBP) in P1 lung was much lower than that in P21 and P70 lungs. While the protein level of LBP was not examined and the mRNA level of LBP may not reflect its final protein level, the reduced transcriptional response of cytokines and chemokines in P1 lung at 2 hours following LPS treatment may be attributed to lower LBP expression in P1 lung as compared to P21 and P70 lungs.

Effects of Maternal Exposure to LPS on the Inflammatory Response in the Offspring

Region Specific Effects of Maternal Immune Activation on Offspring Neuroimmune Function.

Altered hepatic inflammatory response in the offspring following prenatal LPS exposure.

LPS-induced neonatal stress in mice affects the response profile to an inflammatory stimulus in an age and sex-dependent manner.

Effects of Inflammatory Stimulation During Pregnancy on Blood Lipid Levels and Learning and Memory Abilities of Offspring Rats

Maternal Lipopolysaccharide Exposure Promotes Immunological Functional Changes in Adult Offspring CD4+ T Cells

LPS-induced maternal inflammation promotes fetal leukocyte recruitment and prenatal organ infiltration in mice

Prenatal Exposure to Lipopolysaccharide Results in Lipid Metabolism and FAT/CD36 Expression in Mice Offspring

Effects of in utero exposure to inflammation on innate immune response in preterm infants

Maternal Inflammation Exaggerates Offspring Susceptibility to Cerebral Ischemia–Reperfusion Injury Via the COX-2/PGD2/DP2 Pathway Activation

Postnatal development of lipopolysaccharide-induced inflammatory response in the brain

Brief Postpartum Separation from Offspring Promotes Resilience to Lipopolysaccharide Challenge-Induced Anxiety and Depressive-Like Behaviors and Inhibits Neuroinflammation in C57BL/6J Dams

Evaluation of the use of prenatal immune stimulation to alter postnatal immune function in weaned pigs

LPS versus Poly I:C model: comparison of long-term effects of bacterial and viral maternal immune activation on the offspring

Prenatal Programming of Neuroendocrine System Development by Lipopolysaccharide: Long-Term Effects

Prenatal Exposure to Lipopolysaccharide Results in Increases in Blood Pressure and Body Weight in Rats

Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain.

Attenuated Mrna Expression of Inflammatory Mediators in Neonatal Rat Lung Following Lipopolysaccharide Treatment

[Prenatal Exposure to Lipolysaccharide Result in Expression Changes of Myocardial Renin Angiotensin System in Offspring Rats].

CCR2 mediates the adverse effects of LPS in the pregnant mouse

Inhibition of Lipopolysaccharide-Induced Inflammation Via the Protective Role of T Regulatory Cells in the Fetal Liver in a Late-Pregnancy Preterm Mouse Model.